Why New Age Beverages Stock Soared 140% in 2018
Beth McKenna, The Motley Fool
,
Motley Fool•January 14, 2019
What happened
New Age Beverages (NASDAQ: NBEV) stock gained 140% last year, according to data from S&P Global Market Intelligence. For context, the S&P 500 declined 4.4% (including dividends)....
Tilray Surges After Privateer Holdings Vows to Hold Stake Until At Least H2 2019
Martin Baccardax
,
TheStreet.com•January 11, 2019
Privateer Holdings, a a Seattle-based private equity group that limits its investments to the cannabis industry that owns an estimated 76% of Tilary's outstanding shares, said it has a strong belief in Tilray's long-term global growth strategy and its "pioneering role" in shaping the future of the legal marijuana market. "We do not have plans to register, sell or distribute the shares Privateer holds in Tilray during the first half of 2019," Privateer managing partner Michael Blue said in a statement. "When we decide to distribute shares, we will do so in an orderly and deliberate manner to maximize tax-efficiency considerations for Privateer investors, while also taking into consideration potential impacts on Tilray's public float....
https://finance.yahoo.com/m/21…rges-after-privateer.html
.....das tut der ganzen Branche gut!
Canada's pot shortage could last up to 3 years, executives warn
Kristine Owram, Bloomberg News
Canada’s pot shortage could last as long as three years, according to industry executives who say production estimates are too rosy.
Shortages have plagued the country since recreational marijuana was legalized in October. In response, Quebec’s government-controlled stores have closed three days a week, Alberta has temporarily stopped issuing retail licenses and Ontario has said it will initially open just 25 stores across Canada’s most populous province....
......Aurora Cannabis Inc. said Tuesday it expects to report fiscal second-quarter revenue of $50 million to $55 million, below the consensus estimate of $67.4 million. Aurora fell 4.1 per cent to $6.71 in Toronto at 11 a.m.
Trump Signs 2018 Farm Bill
By
12/20/2018
Michael Vadon
President Trump signed into law the 2018 farm bill that modestly strengthens the farm safety net, loosens farm subsidy rules, and legalizes industrial hemp as a crop and then announced he was taking “immediate action on welfare reform” through stricter enforcement of time limits on food stamps to able-bodied people on Thursday.....
https://www.agriculture.com/ne…rump-signs-2018-farm-bill
...ist schon nicht so prickelnd - sobald es legal wird sausen die Aktien runter, war in Kanada auch so
Cannabis Roundup: DAVIDsTEA Preps Earnings, Aurora Cannabis Tumbles
Wall Street is expecting good things from DAVIDsTEA's earnings after the closing bell, sending the stock soaring.
Dec 13, 2018 12:45 PM EST
Pot stocks have had a rocky fourth quarter, with the ETFMG Alternative Harvest ETF (MJ - Get Report) falling 25% over the past three months.
That trend continued Thursday with the largest pot ETF by net asset value falling 1.6%. Alternative Harvest has had a rough fourth quarter since reaching a year-to-date high of up 32% in September.
The industry may be suffering from the bubble that inflated earlier this year as investors overvalued many of the stocks in the sector.
The pot industry, however, got some good news after Congress passed the 2018 Farm Bill, which legalizes the cultivation and farming of hemp, which contains cannabidiol (CBD), the non-psychoactive chemical compound found in cannabis.
Shares of New Age Beverages Corp. (NBEV - Get Report) , which manufactures CBD-infused drinks, jumped more than 11% on the news before pairing all of its gains amid a market selloff.
DAVIDsTEA Inc. (DTEA - Get Report) shares were up 6% ahead of the company's earnings release after Thursday's closing bell.
India Globalization Capital Inc. (IGCC - Get Report) jumped 4% on the CBD news.
Other stocks in the sector traded lower Thursday.
Aurora Cannabis Inc. (ACB - Get Report) shares fell more than than 6% after the company invested $10 million in High Tide, a Canadian cannabis retailer that Aurora says is "developing an expanding network across Canada of cannabis and cannabis accessory retail stores."
Shares of Tilray Inc. (TLRY) were down 10% despite the news that the California Public Employees' Retirement System, the biggest pension fund in the country, owned 1,617 shares of the Canadian cannabis company.
Canopy Growth Corp. (CGC) declined 3.4%, while Cronos Group Inc. (CRON) and Aphria Inc. (APHA) dropped 5.5% and 8%, respectively.
https://www.thestreet.com/inve…o&cm_ven=YAHOO&yptr=yahoo
....nicht so toll
uff.....da kann man kaum durchblicken und nie weiss man sicher wer wirklich im Recht ist.
Hier ein Interview:
Aphria Report Is Not a Condemnation of Pot Sector, Short-Seller Grego Says
December 5th, 2018, 9:36 PM GMT+0100
Gabriel Grego, Quintessential Capital Management founder, explains why he is short Aphria Inc. He speaks with Bloomberg's Caroline Hyde and Scarlet Fu on "Bloomberg Markets: The Close." (Source: Bloomberg)
Aphria habe ich nicht - aber CRON hatte ein ähnliches Schicksal und Aurora ist ja auch nicht auf dem Höhenflug...ich weiss gar nicht ob es sich lohnt dem allen
nachzugehen.
Ben - Du hast sicher noch einiges über APHRIA....ob Aurora auch noch Leichen im Keller hat?
Aphria to review LATAM acquisition in face of 'inaccurate' allegations by short sellers
Tomi Kilgore
,
MarketWatch•December 6, 2018
Shares of Aphria Inc. sank 8.4% in premarket trade Thursday, after the Canada-based cannabis company said it has appointed a special committee to review its LATAM Holdings Inc. acquisition, which was completed in September. The shares had plummeted 43% over the past two sessions, closing Tuesday at a 17-month low, after short seller Quintessential Capital Management said Aphria's recent C$280 million Latin America acquisitions raised "major red flags," as its research suggested they appeared largely worthless, an allegation Aphria denied by saying it "unequivocally" stands behind the LATAM deal. On Thursday, the company said it remained confident in the process leading to the acquisition. "However, in the face of inaccurate and misleading accusations by certain short-sellers, whose sole interest is in profiting from a decline in the Company's shares, it is undertaking a comprehensive review, led by a Special Committee of independent directors of these, and any other, allegations in the interest of protecting Aphria shareholders," Aphria said in a statement. The stock had dropped 72.3% over the past three months, while the ETFMG Alternative Harvest ETF has shed 18.2% and the S&P 500 has lost 6.2%.
*************************
SHARE SHARE SHARE REPOST GREAT FACTS
https://www.reddit.com/r/weeds…_redactors_on_the_aphria/
*****************************
Aphria CEO fires back at short-sellers, vows 'our side of the story'
David George-Cosh, BNN Bloomberg
Aphria Inc. Chief Executive Officer Vic Neufeld is firing back at a short-sellers' report that has sent his company's shares into a tailspin, vowing to soon release more detailed information after the pot producer failed to ease investors' nerves with its initial response.
In a phone interview with BNN Bloomberg, Neufeld said Aphria will soon provide a detailed, line-by-line response to the report released by Hindenburg Research and Quintessential Capital Management (QCM) on Monday that alleges the Leamington, Ont.-based company acquired assets in Jamaica, Argentina and Colombia worth a total of about $280 million at “vastly inflated” prices in a transaction the short-sellers claim benefited a group of insiders.
"We need a complete rebuttal, not a piecemeal rebuttal. There’s lots of allegations of impropriety and we want our deck to speak on the facts," Neufeld said on Wednesday.
In their report, QCM and Hindenburg Research allege that the foreign companies Aphria acquired in Jamaica, Argentina and Colombia appear to be “largely worthless” and that there were "systematic attempts to hide the true nature of these transactions." Both QCM and Hindenburg have taken short positions in Aphria, meaning they stand to benefit if its stock falls......
...gestern hoffte ich auf eine Erholung da die Amis weg waren. Das Gegenteil zB Aurora nochmals fast 13% runter. Möchte gerne wissen wer/was dahinter steckt. Meine ehemaligen Gewinne haben sich mehr als aufgelöst. Dennoch wird immer wieder zum Einstieg getrommelt.....
Pot Stock Plunges 30% After Short Seller Exposes "Elaborate Shell Game"
by Tyler Durden
Mon, 12/03/2018 - 15:01
It's been another volatile session for pot stocks broadly.
[Blocked Image: https://www.zerohedge.com/sites/default/files/inline-images/2018-12-03_11-44-13.jpg]
Day traders could be forgiven for feeling dazed and confused on Monday (for once, it may not have been due to overindulging in their favorite "commodity"). Shares of Tilray, Cronos and other pot stocks fluctuated between gains and losses - while shares of Aphria, another large Canadian pot stock plunged - following two scathing presentations from short sellers during a conference in New York City organized by famed short seller Whitney Tilson......
.....Rounding out the day's pot stock-related news, Reuters reported that Altria was in "early stage" talks to acquire Cronos Group, another Canadian pot producer, as it seeks to diversify its holdings.
Pot stocks have trended lower since Canada legalized recreational cannabis sales back in October. While the sector has largely suffered from a bubble-like influx of capital, concrete reports about a deal where an established beer or tobacco company buys a stake in a cannabis firm - like Constellation brands did with Canopy Growth - could send shares higher.
....da wird nur so rumgeschupst...
https://ridingthebull.whotrades.com/blog/43711790176
an hour ago
Marijuana Stocks Gaining Attention This Week (kann man wohl sagen - leider negative Attention)
The Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF) is currently the largest and most representative marijuana exchange traded fund on the markets. The ETF attempts to duplicate, to an extent, the performance of the North American Marijuana Index, which was created to reveal the performance of a group of North American Life Sciences companies which have a large focus of their business in the marijuana industry.
[Blocked Image: https://cdn-get.whotrades.com/u7/photoB939/20993285257-0/blogpost.jpeg]
Since its initial trading date in April 2017, the marijuana ETF has yielded a return of about 46% and is still up nearly 30% over the last trailing year. For comparison, the SPDR S&P 500 ETF (SPY) gained about 15% during the same time period, while being up just 3.5% over the last year.
Horizons’ Marijuana Life Sciences ETF’s Holdings Include:
Aphria: A Shell Game With A Cannabis Business On The Side
Dec. 3, 2018 8:40 AM ET
About: Aphria Inc. (APHA), Includes: BKDCF, MSRT, RIOT, SOLCF
Hindenburg Investment Research
Activist investor, value, long/short equity
(1,086 followers)
Summary
Aphria’s recent C$280m Latin American acquisitions raise major red flags. Our extensive on-the-ground research shows that the transactions appear to be largely worthless.
Example: The official registered office of Aphria’s C$145m Jamaican acquisition is an abandoned building that was sold off by the bank earlier this year.
Example: Aphria’s C$50m Argentine acquisition publicly boasted sales of US$11m in 2017. A worker at the company, however, affirmed that 2017 revenue was only US$430k.
Documents show that Aphria insiders were likely undisclosed beneficiaries of the deals. We estimate Aphria has diverted upwards of C$700m via such transactions, or ~50% of Aphria’s total net assets.
Aphria consistently generates negative cash, and its cannabis seems to be of low quality. Interviews with sources describe facilities infested with bugs, stricken with mold, and having failed audit inspections.
Background
Any time an exciting new industry draws widespread attention it also draws retail capital, which in turn can draw unscrupulous actors. This is not a story about the cannabis industry and its commercial potential, nor is it a story about valuations and competitive marketplace dynamics. This is simply about one of the larger companies in the industry that appears to have diverted a tremendous amount of money toward the private interests of its insiders at the direct expense of its public shareholders......
https://seekingalpha.com/artic…me-cannabis-business-side
....jetzt haben sie dann bald alle durch mit unendlichen Shortverkäufen - als solche Papiere hoch gingen gab es öfter "halt", jetzt lässt man sie einfach
ins Bodenlose sausen - Börsenaufsicht scheint es nicht zu geben.
Canada’s struggle to supply legal weed described as ‘national shortage’ that could last months
Max A. Cherney
MarketWatch•November 27, 2018
https://www.marketwatch.com/st…?siteid=yhoof2&yptr=yahoo
....dann könnten die Papiere ja wieder mal steigen.... *dirol*
Thanx Ben - habe ich gleich an meine Tochter weitergeleitet.
Canada's Top 7 Marijuana Growers Lost Nearly $300 Million This Quarter
Sean Williams, The Motley Fool
Motley Fool•November 20, 2018
There's no denying that the marijuana industry is growing like a weed. The legalization of recreational marijuana in Canada is big news, and it clearly puts the cannabis industry on the map as a high-growth and viable business model. According to various Wall Street estimates, the legal industry in Canada could see around $5 billion in added annual sales from adult-use pot within a matter of years.
Of course, the expectation of rapid sales growth and (eventual) strong profitability has sent nearly all marijuana stocks soaring. The question is, with recreational cannabis now legal in our neighbor to the north: "Can these pot stocks live up to expectations when it comes time to report their operating results?"
Following earnings releases from all seven of the projected top producers over the last month, the early indication isn't very encouraging.
A rundown of Canada's projected top cannabis producers
As a brief rundown, here are the marijuana stocks expected to lead in annual weed output once at full capacity:
Brand-name growers lost a lot of money in their recently ended quarters.....
Pot stocks: Still 'better at growing their bank accounts than growing cannabis'
3:40 PM ET Wed, 14 Nov 2018
Cannabis companies Tilray, Canopy Growth and Aurora Cannabis all took big stock hits after earnings losses outweighed revenue growth. While demand is high, marijuana growers are struggling to increase supply, and long-term investors should be wary....
Citron Still Short Tilray, Notes Canopy Growth Is The 'Global Leader' In Cannabis
Wayne Duggan
Benzinga•November 12, 2018
Tilray Inc (NASDAQ: TLRY)'s stock is up another 12.5 percent in the past week, but Citron Research’s Andrew Left said he's still short the stock and Canadian marijuana companies will not be the winners from a potential U.S. marijuana legalization.
What Happened?
At the Reuters Global Investment Outlook Summit on Monday, Left said leading Canadian marijuana companies would likely get steamrolled by larger American competitors in the event of U.S. legalization given that there is no brand value or competitive moat in the U.S. cannabis business.
“When U.S. LPs (companies) go public in the next few years it will make these Canadian companies laughable,” Left said.
Why It’s Important
Tilray shares are now up 339 percent in the past three months, and the U.S.-listed Canadian cannabis company isn't alone:
Canadian marijuana stocks have capitalized on investor enthusiasm following nationwide recreational cannabis legalization in Canada in October and state legalization measures approved by U.S. voters last week in Michigan and Missouri.
Left said he understands why investors are excited about the cannabis market but said Tilray is a dangerous way to play the trend. Right now, Left said Canopy Growth is the global market leader, although he has no position in the stock....
https://finance.yahoo.com/news…lray-notes-193604720.html
.....dieser Citron-Left fällt hoffentlich mal ordentlich auf die Nase mit seiner ewigen Shorterei *bomb*
Marihuana-Aktien steigen nach Sessions-Rücktritt massiv
Dem US-Justizminister war Cannabis ein Dorn im Auge. Sein Abgang war daher in der Branche unmittelbar spürbar, einige Aktien legten gar um über 30 Prozent zu. Mehr...
